BeyondSpring (NASDAQ:BYSI – Get Rating) had its price target decreased by investment analysts at Robert W. Baird from $11.00 to $4.00 in a report released on Wednesday, The Fly reports. Robert W. Baird’s price target suggests a potential upside of 220.00% from the company’s current price.
BeyondSpring Stock Performance
Shares of BYSI opened at $1.25 on Wednesday. The stock has a fifty day moving average price of $2.14 and a two-hundred day moving average price of $1.44. BeyondSpring has a 52-week low of $0.54 and a 52-week high of $3.45. The company has a market cap of $48.66 million, a price-to-earnings ratio of -0.71 and a beta of 0.11.
Institutional Investors Weigh In On BeyondSpring
Several hedge funds and other institutional investors have recently made changes to their positions in the company. BlackRock Inc. increased its stake in shares of BeyondSpring by 20.8% in the 1st quarter. BlackRock Inc. now owns 1,861,219 shares of the company’s stock valued at $4,095,000 after buying an additional 320,428 shares during the period. Millennium Management LLC increased its stake in shares of BeyondSpring by 78.0% in the 2nd quarter. Millennium Management LLC now owns 691,826 shares of the company’s stock valued at $996,000 after buying an additional 303,184 shares during the period. State Street Corp increased its stake in shares of BeyondSpring by 11.5% in the 1st quarter. State Street Corp now owns 563,670 shares of the company’s stock valued at $1,240,000 after buying an additional 57,933 shares during the period. Renaissance Technologies LLC increased its stake in shares of BeyondSpring by 30.0% in the 2nd quarter. Renaissance Technologies LLC now owns 366,959 shares of the company’s stock valued at $528,000 after buying an additional 84,586 shares during the period. Finally, BNP Paribas Arbitrage SA increased its stake in shares of BeyondSpring by 89.6% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 249,308 shares of the company’s stock valued at $359,000 after buying an additional 117,831 shares during the period. 18.14% of the stock is owned by institutional investors and hedge funds.
BeyondSpring Company Profile
BeyondSpring, Inc engages in the development and commercialization of immuno-oncology cancer therapies. It operates through the PRC and U.S. geographical segments. The company was founded by Lan Huang and Lin Qing Jia in 2010 and is headquartered in New York, NY.
- Get a free copy of the StockNews.com research report on BeyondSpring (BYSI)
- Don’t Miss Out: $2 Trillion Could be Headed to the Banking Sector
- A Weakening Economy Suggests Caution Before Buying Five Below
- Williams-Sonoma: Time To Buy At Rock-Bottom Prices
- Why DraftKings Could Keep Outperforming in 2023
- Charles Schwab And The Safest 30% You Can Make This Year
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.